Clinical Trials Sponsored by AAK

Total 241 results

Wageningen University and Research
AAK

Completed

Choline Uptake Study (CUP)

Choline Uptake | Kinetics

Netherlands
Ask Rose

Unknown

Examining the Feasibility of a Mobile Mental Health Application in Psychotherapy

Depression | Mental Health Wellness 1

United States
ABK Biomedical

Recruiting

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Liver Cancer | Hepatocellular Carcinoma Non-resectable

United States
ABK Biomedical

Completed

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC

Metastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectable

New Zealand
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Oak Valley Health

Recruiting

ED Adaptive Staffing Study (FAST-ED)

Emergency Medicine | Well-Being, Psychological

Canada
TAK-Circulator Co.

Completed

The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males.

Healthy Volunteer

Japan
Ark Biosciences Inc.

Unknown

Anti-RSV Study in Chinese Patients (ASCENT) (ASCENT)

Respiratory Syncytial Virus Infections

China
Ark Biosciences Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529

Healthy

United Kingdom
Technische Universität Dresden
AOK Bayern; Techniker Krankenkasse; InGef - Institut für angewandte Gesundheitsforschung... and other collaborators

Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data (POINTED)

Virus Diseases | Epidemiology

Germany
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Hypertrophic Scar

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Completed

A Study of AK3280 in Chinese Healthy Volunteers

Healthy

China
Ark Biosciences Inc.

Completed

A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers

Healthy

China
Ark Biosciences Inc.

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects

Healthy Subjects

United States
Ark Biosciences Inc.

Completed

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

Healthy

Sweden
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
Ark Biosciences Inc.

Completed

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Respiratory Syncytial Virus Infections

Australia
Ark Therapeutics Ltd

Terminated

Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence (AdV-VANTAGE)

End Stage Renal Disease

United States
Bispebjerg Hospital
AAL; Innovationsfonden

Recruiting

Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients (SENS4ME)

Heart Failure | Arthritis | Parkinson Disease | Stroke Sequelae | COPD | Old Age; Cachexia

Denmark
Pak Emirates Military Hospital

Recruiting

Auto-inoculation of a Wart in Multiple Viral Warts

Viral Wart | Delayed Hypersensitivity

Pakistan
ALK-Abelló A/S

Enrolling by invitation

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Allergic Asthma | Allergic Rhinitis Due to House Dust Mite

China
Pak Emirates Military Hospital

Completed

Comparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination Ointment

Plaque Psoriasis

Pakistan
Oak Hill Bio Ltd

Terminated

Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants

Intraventricular Hemorrhage | Bronchopulmonary Dysplasia | Chronic Lung Disease of Prematurity | Retinopathy of Prematurity (ROP)

United States, Italy, United Kingdom
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® (GT-20)

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) (AIRS)

Allergic Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

Allergy
ALK-Abelló A/S

Completed

Grazax Asthma Prevention (GAP)

Allergic Rhinitis

Finland
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis

Allergic Rhinitis

China
ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy (AV-M-01)

Allergic Rhinitis Due to Dust Mite

Spain
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine (GT-19)

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (GT-17)

Allergic Rhinitis | Grass Allergy

Italy
ALK-Abelló A/S

Completed

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Grass Pollen Allergy

Denmark
ALK-Abelló A/S

Terminated

Comparison of Different Up-dosing Schedules With Osiris

Allergic Rhinitis

Poland
ALK-Abelló A/S

Completed

Safety of ALK Ragweed Tablet

Allergy

United States
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biosciences Pty Ltd.

Completed

Viral Inhibition in Children for Treatment of RSV (VICTOR)

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Australia, Hong Kong, Israel, Lebanon, Malaysia, Poland, Taiwan, Turkey
Pak Emirates Military Hospital

Recruiting

Incidence of Regurgitation in Patients Undergoing Intubation in Semi-fowler v/s Supine Position

Inguinal Hernia Bilateral

Pakistan
ALK-Abelló A/S

Recruiting

Observational Study of Allergic Rhinitis in Children (ORACLE)

Allergic Rhinitis

France
Pak Emirates Military Hospital

Recruiting

Effect of Preoperative High-dose Cholecalciferol in Prevention of Post-thyroidectomy Hypocalcaemia

Hypocalcemia

Pakistan
ALK-Abelló A/S

Active, not recruiting

House Dust Mite Allergy Trial In Children (MATIC)

Allergic Rhinitis Due to Dermatophagoides Farinae | Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Allergic Rhinitis Due to House Dust Mite

Spain, Russian Federation, United States, Poland, Bulgaria, Canada, France, Germany, Lithuania, Slovakia, Ukraine
Pak Emirates Military Hospital

Completed

Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris

Acne Vulgaris

Pakistan
Pak Emirates Military Hospital

Completed

Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.

Terbinafine Adverse Reaction | Dermatophyte Infection | Itraconazole Adverse Reaction

Pakistan
Pak Emirates Military Hospital

Completed

Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy

Blood Loss, Surgical | Uterine Myoma

Pakistan
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

Allergic Rhinitis Due to Grass Pollens

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (MT-06)

House Dust Mite Allergy

France
ALK-Abelló A/S

Completed

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Allergy

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

Atopic Dermatitis

Germany

Clinical Trials Sponsored by AAK

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations